Showing Results for: “type 1 diabetes”

American Diabetes Association’s Project Power is helping turn a type 2 diagnosis into healthy action The American Diabetes Association ® (ADA) and partner CVS Health today announced the expansion of Project Power , an innovative diabetes lifestyle change program that will raise diabetes awareness, help combat disparities in diagnosis among communities of color, and offer diabetes risk reduction education to people with type 2 diabetes and prediabetes nationwide. Project Power is a no-cost program that uses an outcomes-based curriculum. With support from strategic partner CVS Health , the ADA

Jennifer Holdgreve from Centreville, Maryland, is the mother of Allison, age 8. Allison was diagnosed with type 1 diabetes when she was six years old. This is her story: Parents Talking Type 1 Allison was diagnosed with type 1 diabetes on May 1, 2011. We remember it like it was yesterday, but at the same time, it now feels like diabetes has always been a part of our lives. She had the classic symptoms of fatigue, weight loss, extreme thirst, extreme hunger and using the bathroom all the time. Of course we knew nothing about diabetes, so we did not realize the seriousness of what was happening

Patricia is a Pilates instructor living with type 1 diabetes. Though she has experienced diabetes-related complications, she has refused to let them keep her down. This is her story: For the last 17 years, I have been without one eye. I wear a prosthetic eye hand-painted to "look normal" during the day. Type 1 diabetes has stolen my vision. My parents were sure that I must have type 1 diabetes as a child. My mother developed gestational diabetes when she was pregnant with me, then became a type 1 insulin-dependent diabetic a few years later. She died at 69 from diabetic complications, though

2021 marks 30 years of living with diabetes. When I was diagnosed at 10 years old it was such a different time and I didn’t have the same tools that others so readily have available today. Regardless, transitioning to life with diabetes can be hard and isolating. Luckily, with the help of a neighbor with Type 2 diabetes and a youth camp, I learned much about diabetes and the importance of being in control of my health. Early on, I struggled to stay on top of my diabetes. I was burnt out and, as a result, my diabetes and eye health suffered. Ironically, I was diagnosed with diabetic retinopathy

Mary Van Doorn, a mother of two from Dacula, Georgia, was diagnosed with type 2 diabetes—but her diagnosis didn’t hold her back. Mary founded Sugar Mama Strong, a diabetes support group and wellness program for women. This is her story: I was diagnosed with type 2 diabetes when I was just 21 years old, the daughter of two type 2 parents. Our genetics run deep—almost every adult on my mother's side now lives with type 2. At first, I ignored it. I lived in denial for a long time—I call it my young and stupid phase. At 21, you think you're invincible. I didn't FEEL sick. I didn't LOOK sick. It

Patricia is a Pilates instructor living with type 1 diabetes. Though she has experienced diabetes-related complications, she has refused to let them keep her down. For the last 17 years, I have been without one eye. I wear a prosthetic eye hand-painted to "look normal" during the day. Type 1 diabetes has stolen my vision. My parents were sure that I must have had type 1 diabetes as a child. My mother developed gestational diabetes when she was pregnant with me, then became a type 1 insulin-dependent diabetic a few years later. She died at 69 from diabetic complications, though she always had

Learn more about the Better Choices for Life program, product types eligible under the program including products designed specifically for diabetes management.

The New England Journal of Medicine: AMPLITUDE O trial reveals regular use of efpeglenatide has potential to improve outcomes for high-risk diabetes patients with heart or kidney disease Data released today from a large-scale, international clinical trial show significant reduction in the first occurrence of a heart attack, stroke, or death, and a reduction in progression of kidney disease in patients with type 2 diabetes with weekly use of efpeglenatide, an injectable drug with glucose- and weight-lowering effects. The findings were presented at the virtual 81st Scientific Sessions of the

Novel Weight Loss Drug, Survodutide, Shows Significant Weight Loss of Nearly 19% At 46 Weeks Oral Semaglutide Demonstrates Weight Loss Up to 15% for People with Obesity and Improved Management of Type 2 Diabetes Late breaking data focused on new drug therapy innovations to treat obesity were presented at the American Diabetes Association’s ® (ADA) 83rd Scientific Sessions in San Diego, CA. Two of the studies were also simultaneously published in The Lancet . This comes at a time when more than 37 million Americans live with diabetes, and nearly 90% of people with diabetes are overweight or